Elias Ilin specializes in patent damages analysis, with a focus on lost profits, reasonable royalties, and damages apportionment. Dr. Ilin quantifies patent damages in a variety of complex industries, including biopharmaceuticals and semiconductor manufacturing. His case experience in breach of contract matters includes analysis of claims related to irreparable harm and quantifiable damages.
Dr. Ilin also consults on matters at the intersection of antitrust and intellectual property, where he addresses issues related to market definition, competitive injury, and damages. He has worked on trademark dilution cases in the automotive industry and designed consumer surveys to estimate the value of patented features.
Selected industry experience
- Biopharmaceuticals, biotechnology, entertainment, semiconductors, and software.
Previous experience
- Federal Reserve Bank of Atlanta
The Knowledge Economy: Nobel Laureates Highlight Innovation and Intellectual Property as Keys to Sustained Economic Growth